Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Alessandra Gennari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of a prediction algorithm of endocrine responsiveness in ER+ metastatic breast cancer
Gennari, A. (PI)
AIRC - Fondazione AIRC per la Ricerca sul Cancro
9/01/18 → 31/10/18
Project: Research
-
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings
Romanisio, M., Daffara, T., Pitino, R., Ferrero, A., Pizzolitto, F., Zavattaro, M., Biello, F., Gennari, A., Volpe, A., Sacchetti, G. M., Marzullo, P., Aimaretti, G., Prodam, F. & Caputo, M., Jan 2025, In: Endocrine. 87, 1, p. 325-333 9 p., 20170520.Research output: Contribution to journal › Article › peer-review
Open Access -
Anaemia in cancer patients: Advances and challenges in the era of precision oncology
Miglietta, F., Pirozzi, M., Bottosso, M., Pisani, C., FRANCO, P., Guarneri, V. & Gennari, A., 2025, In: CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. 213, p. 1-12 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management
Nardin, S., Ruffilli, B., Landolfo, T. L., Isingrini, G., Taglialatela, I., Delbarba, A., D’Avanzo, F., Rossi, V., Celentano, E., Conte, B., Nardin, M. & Gennari, A., Sept 2025, In: Cancers. 17, 17, 2726.Research output: Contribution to journal › Review article › peer-review
Open Access -
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
Schettini, F., Nucera, S., Di Grazia, G., Giudici, F., Strina, C., Milani, M., Tancredi, R., Conte, B., Criscitiello, C., Giuliano, M., Lambertini, M., Sánchez-Bayona, R., Pascual, T., Arpino, G., Del Mastro, L., Vigneri, P., Cristofanilli, M., Rugo, H. S., Gennari, A. & Curigliano, G. & 1 others, , 1 Oct 2025, In: JNCI Cancer Spectrum. 9, 5, pkaf083.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis
Schettini, F., Nucera, S., Pascual, T., Martínez-Sáez, O., Sánchez-Bayona, R., Conte, B., Buono, G., Lambertini, M., Punie, K., Cejalvo, J. M., Arpino, G., Vigneri, P., Generali, D., Ciruelos, E., Cortés, J., Gennari, A., Muñoz, M., Vidal Losada, M. J., Tolaney, S. M. & Prat, A. & 1 others, , Jan 2025, In: Cancer Treatment Reviews. 132, 102865.Research output: Contribution to journal › Review article › peer-review
Open Access